3-(2-chloro-6-methyl-pyrimidin-4-ylamino)-propan-1-ol | 55662-20-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 3-(2-chloro-6-methyl-pyrimidin-4-ylamino)-propan-1-ol
• 英文别名: 1-Propanol, 3-[(2-chloro-6-methyl-4-pyrimidinyl)amino]-；3-[(2-chloro-6-methylpyrimidin-4-yl)amino]propan-1-ol
• CAS: 55662-20-9
• 化学式: C₈H₁₂ClN₃O
• 分子量: 201.656
• InChiKey: UETBYRLLJGPKBG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  58
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2-chloro-6-methyl-pyrimidin-4-ylamino)-propan-1-ol 在 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 sodium hydride 、 sodium carbonate 、 三苯基膦 、 1,1'-azodicarbonyl-dipiperidine 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成
  参考文献：
  名称：

  Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

  摘要：

  Modulation of PPAR activities represents an attractive approach for the treatment of diabetes with associated cardiovascular complications. The indanylacetic acid structural motif has proven useful in the generation of potent and tunable PPAR ligands. Modification of the substituents on the linker and the heterocycle tail group allowed for the modulation of the selectivity at the different receptor subtypes. Compound 33 was evaluated in vivo, where it displayed the desired reduction of glucose levels and increase in HDL levels in various animal models. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.11.025
• 作为产物：
  描述：

  2,4-二氯-6-甲基嘧啶 、 3-氨基-1-丙醇 在 碳酸氢钠 作用下， 以 乙醇 为溶剂， 生成 3-(2-chloro-6-methyl-pyrimidin-4-ylamino)-propan-1-ol
  参考文献：
  名称：

  Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

  摘要：

  Modulation of PPAR activities represents an attractive approach for the treatment of diabetes with associated cardiovascular complications. The indanylacetic acid structural motif has proven useful in the generation of potent and tunable PPAR ligands. Modification of the substituents on the linker and the heterocycle tail group allowed for the modulation of the selectivity at the different receptor subtypes. Compound 33 was evaluated in vivo, where it displayed the desired reduction of glucose levels and increase in HDL levels in various animal models. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.11.025

文献信息

• Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists
  作者：Louis-David Cantin、Sidney Liang、Herbert Ogutu、Christiana I. Iwuagwu、Ken Boakye、William H. Bullock、Michael Burns、Roger Clark、Thomas Claus、Fernando E. delaCruz、Michelle Daly、Frederick J. Ehrgott、Jeffrey S. Johnson、Christine Keiper、James N. Livingston、Robert W. Schoenleber、Jeffrey Shapiro、Christopher Town、Ling Yang、Manami Tsutsumi、Xin Ma

  DOI：10.1016/j.bmcl.2006.11.025

  日期：2007.2

  Modulation of PPAR activities represents an attractive approach for the treatment of diabetes with associated cardiovascular complications. The indanylacetic acid structural motif has proven useful in the generation of potent and tunable PPAR ligands. Modification of the substituents on the linker and the heterocycle tail group allowed for the modulation of the selectivity at the different receptor subtypes. Compound 33 was evaluated in vivo, where it displayed the desired reduction of glucose levels and increase in HDL levels in various animal models. (c) 2006 Elsevier Ltd. All rights reserved.